ELISA (Figure 3D–F) further showed dose-dependent reductions in the release of key inflammatory mediators: interferon-β (IFN-β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), all of which were significantly different (all p < 0.05) from those in WT infection. This evidence concerns the gene IL6 and infection.